INTESTINAL ADENOCARCINOMA

This adverse event was reported 187 times

These drugs are most commonly taken by patients reporting INTESTINAL ADENOCARCINOMA:

# Drug Count
0 INFLIXIMAB 22
1 METHOTREXATE SODIUM 21
2 METHOTREXATE 18
3 ADALIMUMAB 15
4 PREDNISONE 13
5 ETANERCEPT 11
6 LENALIDOMIDE 11
7 TACROLIMUS 11
8 AZATHIOPRINE 10
9 OXALIPLATIN 10
See all common drugs associated with INTESTINAL ADENOCARCINOMA

INTESTINAL ADENOCARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ESTRADIOL VALERATE 4 0.0051
1 DIMETICONE 1 0.0035
2 ATENOLOL AND CHLORTHALIDONE 1 0.0013
3 ALMOTRIPTAN 1 0.0009
4 DANTROLENE SODIUM 1 0.0009
5 CLEMASTINE FUMARATE 1 0.0007
6 PROPAFENONE 3 0.0007
7 IBRITUMOMAB TIUXETAN 1 0.0007
8 INSULIN DEGLUDEC AND LIRAGLUTIDE 1 0.0006
9 INFLIXIMAB-DYYB 2 0.0006
See all drugs enriched for association with INTESTINAL ADENOCARCINOMA